Account
Asymmetrique bags Concorde Group’s creative mandate
MUMBAI : Digital branding and media agency Asymmetrique has bagged the creative duties for Bengaluru-based real estate player, Concorde Group. The account will be handled out of Asymmetrique’s Mumbai office.
Concorde Group sales and marketing head Raja Mujherjee said, “What attracted us to Asymmetrique is their experience in the real estate market spanning segments across affordable housing to luxury residences. Concorde has been growing really fast, and has projects starting at 40L upto 1Cr. We have launched our first luxury product in the market, at the heart of Bangalore, Bull Temple Road, Chamrajpet. Asymmetrique currently has the integrated mandate and will offer creative services to Concorde Group across traditional and digital media”
Commenting on the win Asymmetrique business head Dhiiraj Kapoor said, “Concorde Group has very strong business fundamentals and a new-age marketing-driven mindset. We are excited at this opportunity, because of the trust they have shown in us. We’re confident that with the belief and collaboration from the entire team at Concorde Group, we will succeed in propelling their growth forward.”
Concorde Group has developed close to 60 lakhs square feet of land into residential layouts and 350,000 square feet of land into constructional projects. Concorde Group currently has 750 crore worth of projects, due for completion in the next three years.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
